Liberia Medicines & Health Products Regulatory Authority

Liberia Medicines & Health Products Regulatory Authority LMHRA is charged with the responsibilty to ensure that all medicines and health products consume in Liberia are safe, effective and of good quality

PMCS Team Reviews LMHRA’s 2026 Performance TargetsMonrovia, Liberia – September 3, 2026 — A verification team from the G...
03/09/2026

PMCS Team Reviews LMHRA’s 2026 Performance Targets

Monrovia, Liberia – September 3, 2026 — A verification team from the Government of Liberia’s Performance Management and Compliance System (PMCS), led by Mr. G. Shardrick Bloyue, visited the Liberia Medicines & Health Products Regulatory Authority (LMHRA) headquarters to review the institution’s performance targets and achievements for the year as part of the PMCS 2026 Mid-Year Review.

The verification exercise is part of ongoing efforts to ensure that reported results are supported by credible evidence, thereby strengthening the integrity, fairness, and credibility of the PMCS framework.

Making opening remarks, Team Lead, Bloyue disclosed that the assessment provides institutions the opportunity to demonstrate their achievements, validate reported results, and identify areas requiring further improvement.

He emphasized that the Government of Liberia is committed to using credible information to enhance decision-making, accountability, performance improvement, and service delivery. Bloyue noted that highlights from institutions completing the verification process will be shared as the review continues.

Dr. S. Michael Chu Nepay, LMHRA’s PMCS Technical Focal Person and Director of Program, Planning, Monitoring, Evaluation, Research, and Statistics (PPMERS), commended the initiative. He stressed that the review and working session would help LMHRA address identified gaps and align more closely with PMCS standards.

Dr. Nepay pledged LMHRA’s commitment to strengthening institutional systems, noting that the exercise was timely and essential for sustaining credibility.

He highlighted LMHRA’s strategic priorities for 2026, including to include the decentralization plan to expand regulatory reach; the Strategic Plan for long-term institutional growth; establishment of a Pharmaceutical Waste Disposal Site, the construction of the State-of-the-Art Ultra Quality Control Laboratory; the implementation of a Track and Trace System for medicines; the ex*****on of the Annual Work plan, Procurement Plan and an updated Human Resource Plan to strengthen workforce capacity.

The Performance Management and Compliance System (PMCS) is a government-wide initiative designed to promote transparency, accountability, and evidence-based decision-making across public institutions.

LMHRA Launches 10-Day Benchmarking Exercise To Elevate Medicines StandardsMONROVIA, Liberia – August 31, 2026 — The Libe...
01/09/2026

LMHRA Launches 10-Day Benchmarking Exercise To Elevate Medicines Standards

MONROVIA, Liberia – August 31, 2026 — The Liberia Medicines & Health Products Regulatory Authority (LMHRA) has officially launched a 10-day self-benchmarking exercise, marking a decisive step toward aligning Liberia’s medicine quality standards with international best practices.
At the opening session, held at the LMHRA headquarters, Managing Director Hon. Luke L. Bawo commended the institution’s Quality Management System (QMS) Unit, under the supervision of Dr. Thomas B. L. Kokulo, for driving the agency’s push toward global recognition.
“Benchmarking is a critical initiative that both our region and the continent recognize as essential,” Bawo said. “Every national regulatory authority must work toward global accreditation. LMHRA is already deep in this process. I am proud to see our team so eager to elevate this entity to the highest standard; this is what fulfilling our mandate is all about.”
The benchmarking exercise is designed to prepare LMHRA for World Health Organization (WHO) Maturity Level-3 Accreditation and ISO 17025 Certification for its Quality Control Laboratory. These milestones will significantly strengthen Liberia’s regulatory credibility and position the country as a leader in medicine regulation within West Africa.
Dr. Kokulo emphasized the collective effort behind the initiative, noting that achieving these accreditations would transform Liberia’s public health standing.
“When we secure these accreditations, Liberia will be internationally recognized. New grant opportunities will open up, and our country can become a regional hub for regulatory training,” he said.
To ensure the process meets international standards, LMHRA is collaborating directly with the World Health Organization to conduct joint benchmarking assessments. This partnership will help evaluate the agency’s operational readiness and determine whether Liberia can achieve full WHO Maturity Level 3 status by 2028.
WHO Maturity Level 3 is a globally recognized benchmark for regulatory authorities, signaling strong capacity to ensure medicine safety and efficacy. ISO 17025 certification is an international accreditation for testing laboratories, ensuring that results are reliable and accepted worldwide. Global benchmarking standards would also open doors to funding, partnerships, and training opportunities across Africa and beyond.
This initiative underscores LMHRA’s determination to transform Liberia’s public health landscape, moving the country closer to international accreditation and reinforcing its role in protecting citizens from substandard and counterfeit medicines.

“LMHRA Charges Pharmacy Technicians To Put Patient Safety, Ethics And Professional Excellence First”  (MONROVIA—Septembe...
01/09/2026

“LMHRA Charges Pharmacy Technicians To Put Patient Safety, Ethics And Professional Excellence First”

(MONROVIA—September 1, 2026) The Managing Director of the Liberia Medicines & Health Products Regulatory Authority (LMHRA), Dr. Luke Bawo, has challenged newly certified pharmacy technicians to make patient safety, professional integrity, accountability, competence, and ethical practice the cornerstones of their careers as they enter Liberia’s healthcare system.

The call was made on behalf of the LMHRA Managing Director, Bawo, during the Liberia Health Management Sciences University (LIHMSU) Oath and Honors Program for Pharmacy Technicians held in Monrovia on August 29, 2026.

Representing the Managing Director, Dr. S. Michael Chu Nepay, Director of Program Planning, Evaluation, Monitoring, Research and Statistics (PPMERS), delivered the Keynote address under the theme, “The Benefits of Becoming a Certified Pharmacy Technician.”

Speaking on behalf of the LMHRA Managing Director, Dr. Nepay highlighted ongoing LMHRA efforts to strengthen medicines regulation and public health protection across Liberia. He emphasized that effective medicines regulation requires collaboration among manufacturers, importers, distributors, healthcare institutions, pharmacists, pharmacy technicians, other healthcare professionals, and patients.

Dr. Nepay congratulated the graduating pharmacy technicians and commended LIHMSU’s administration and faculty for their contribution to developing a new cadre of healthcare professionals for Liberia.

He emphasized that professional certification represents more than an academic achievement; it marks the beginning of a responsibility to patients, communities, and the broader healthcare system.

“An honor says, ‘You have done well.’ An oath says, ‘Now, this is what is expected of you.’”
Dr. Nepay stressed that professional success must be demonstrated not merely through academic credentials, but through accuracy, integrity, responsible handling of medicines, respectful patient care, and strict adherence to professional standards.
He identified patient safety as a fundamental responsibility of pharmacy technicians, noting that medicines are not ordinary commodities but critical healthcare interventions on which patients depend. He therefore urged the new professionals to exercise the highest level of diligence in medicine handling and storage, inventory and stock management, documentation, communication, and support for accurate dispensing.

“Never underestimate the significance of your role,” he cautioned, noting that seemingly minor errors in medicine-related activities can have serious consequences for patients and undermine public confidence in the healthcare system. Dr. Nepay encouraged the new professionals to build confidence while remaining humble enough to recognize the limits of their knowledge, skills, and professional authority.

He urged them to seek guidance whenever necessary, emphasizing that asking for assistance is not a weakness but a critical component of responsible professional practice. Particular emphasis was placed on understanding and respecting the scope of practice of pharmacy technicians.

“Knowing your scope of practice is itself a form of competence,” Dr. Nepay stated. He explained that knowing when to consult pharmacists or other appropriately qualified professionals protects both the pharmacy technician and, most importantly, the patient.

The LMHRA representative further challenged the graduates to view certification as the beginning—not the end—of their professional development. According to him, Liberia’s pharmaceutical and healthcare environment continues to evolve in response to new medicines, technologies, regulatory requirements, professional practices, and changing patient needs.

He therefore encouraged the technicians to embrace lifelong learning by reading, asking questions, participating in professional development programs, learning from experienced colleagues, accepting constructive criticism, and remaining open to new knowledge.

“The best professionals are not those who believe they know everything. They are those who remain curious enough to keep learning.” Dr. Nepay also reminded the graduates that their responsibilities extend beyond individual career advancement. Liberia, he said, needs a competent, ethical, and committed healthcare workforce capable of treating healthcare as both a profession and a public service.

He challenged each graduate to consider the broader impact of their professional choices: “What kind of healthcare professional will I become, and what kind of health system will my work help create?” Accordingly, he said: “Strong regulation requires strong professional practice, and strong professional practice contributes to a safer medicines environment.”

Nepay disclosed that the LMHRA is working toward the decentralization of regulatory services to all 15 counties by the first quarter of 2027. The initiative will be implemented in phases, beginning with selected counties before progressively expanding nationwide. The effort is expected to involve regulatory pharmacists, public health technicians, pharmacy technicians, and other relevant personnel, bringing regulatory services closer to communities throughout Liberia.

Dr. Nepay also disclosed that the LMHRA has opened its pharmaceutical waste management site in Koko Town, Ziwor Road, Lower Margibi County. The facility is expected to strengthen Liberia’s capacity to safely manage and dispose of pharmaceutical waste while promoting responsible environmental and public health practices.

He further highlighted the Authority’s partnership with Quality Management Solutions under a public-private partnership arrangement to establish a state-of-the-art Quality Control Laboratory.
According to Dr. Nepay, the facility is expected to enhance Liberia’s scientific capacity to test medicines, herbal products, and medical devices, while supporting third-party testing of food and petroleum products.

The expanded laboratory capacity is expected to provide a stronger scientific foundation for medicines regulation, product quality assurance, and public health protection. As the graduates prepared to take their professional oath, Dr. Nepay reminded them that the oath must extend beyond the ceremony and become a standard for everyday professional conduct.

He added: “An oath has no value if it is only spoken. Its value is demonstrated through action.”
Dr. Nepay congratulated the newly certified pharmacy technicians and honorees on behalf of Managing Director Dr. Bawo and the entire LMHRA. He urged them to remain humble, teachable, ethical, and committed to professional excellence throughout their careers.

He also commended LIHMSU’s faculty and administration for their contribution to Liberia’s healthcare workforce and recognized the parents, families, and supporters whose sacrifices helped the graduates reach the professional milestone.

Administering the Oath & Honor, the Registrar of the Pharmacy Board of Liberia, Dr. Menlor P. Z. Dunah, congratulated the graduating class and LIHMSU’s management for their sustained efforts in producing pharmacy technicians capable of contributing meaningfully to Liberia’s healthcare system.

Dr. Dunah disclosed that, in collaboration with the Ministry of Finance and Development Planning, Ministry of Health, and other stakeholders, discussions are underway toward the reclassification of pharmacy technicians, consistent with developments affecting other healthcare professionals.

Speaking on behalf of the graduating class, Meshach Gbollie, President of the graduating class, encouraged his colleagues to use their newly acquired knowledge and professional responsibilities to serve the public and act as responsible gatekeepers of medicines.
He urged pharmacy technicians to ensure that medicines are properly preserved, handled, managed, and dispensed in accordance with professional standards.
Gbollie also called for the Government to reclassify pharmacy technicians and create stronger opportunities for their professional advancement and continuing development in an increasingly evolving global health sector.

The LMHRA reaffirmed its commitment to working with academic institutions, healthcare professionals, regulatory stakeholders, and development partners to strengthen Liberia’s medicines regulatory system and advance a safer, more effective, accountable, and quality-driven healthcare environment for all Liberians.
— END —

LMHRA Deputy Managing Director Appointed To Africa CDC Technical Working GroupAddis Ababa, Ethiopia— The Deputy Managing...
18/08/2026

LMHRA Deputy Managing Director Appointed To Africa CDC Technical Working Group

Addis Ababa, Ethiopia— The Deputy Managing Director of the Liberia Medicines & Health Products Regulatory Authority (LMHRA), Dr. Patricia Quaye-Freeman, has been appointed to the African Pooled Procurement Mechanism (APPM) Technical Working Group following her active participation in high-level consultations convened by the Africa Centres for Disease Control and Prevention (Africa CDC) in Addis Ababa, Ethiopia.

The consultations brought together representatives from 14 African Union Member States, including procurement agencies, national regulatory authorities, and ministries of health, to advance discussions on the operationalization of the APPM, developments in local pharmaceutical manufacturing, and strategies to expand access to quality-assured medicines, vaccines, medical equipment, and other essential health products across Africa.

Dr. Quaye-Freeman made significant contributions to the discussions through technical presentations and interventions focused on strengthening regulatory systems, improving procurement coordination, and advancing sustainable access to health products. Her contributions were recognized by participants and subsequently led to her appointment to the APPM Technical Working Group.

In her new role, Dr. Quaye-Freeman is expected to contribute to efforts aimed at aggregating demand, increasing procurement from African manufacturers, strengthening regional supply chains, and promoting equitable access to quality-assured health products across the continent.

The APPM is an Africa CDC-led initiative designed to strengthen Africa’s collective purchasing power by pooling demand for essential health products. By consolidating procurement needs across countries, the mechanism seeks to improve market efficiency, reduce fragmentation, and create stronger incentives for investment in Africa’s pharmaceutical and health-product manufacturing sector.

The initiative is also aligned with the African Union’s broader objective of increasing domestic production of health products, including the target of manufacturing at least 60 percent of the continent’s health products domestically by 2040, as endorsed by AU Heads of State and Government.
During the Addis Ababa consultations, participating Member States underscored the importance of national ownership, political commitment, coordinated action, and sustained investment in making pooled procurement effective. Discussions also examined how collective purchasing could reduce procurement fragmentation, strengthen regional supply chains, and provide greater market visibility and predictability for manufacturers and investors operating within Africa.

Africa CDC has framed the APPM around three interconnected priorities:
Manufacture Africa — promoting industrial development and expanding the continent’s capacity to manufacture essential health products;
Procure Africa — strengthening pooled and coordinated purchasing mechanisms to improve procurement efficiency and Africa’s bargaining power; and
Regulate Africa — advancing regulatory strengthening and harmonization of standards across Member States.

The APPM builds on lessons learned from the Africa Medical Supplies Platform (AMSP), which was established during the COVID-19 pandemic to address critical supply challenges. The pooled procurement initiative is supported technically and financially by development and international partners, including the World Bank, European Union, Unitaid, UNFPA, and UNICEF.

The COVID-19 pandemic exposed significant vulnerabilities in Africa’s dependence on international supply chains, particularly as export restrictions, production bottlenecks, and intense global competition affected access to vaccines, medicines, and other essential medical commodities.

Against this backdrop, strengthening regional supply chains and developing more coordinated procurement and regulatory systems have become key priorities for African health institutions. The integration of national regulatory authorities into the APPM’s governance structure is intended to help address longstanding challenges associated with fragmented procurement systems, differing regulatory requirements, and limited coordination among Member States.

Dr. Quaye-Freeman’s appointment to the Technical Working Group represents a significant opportunity for Liberia to contribute directly to the development of a continental mechanism aimed at improving the availability, affordability, quality, and security of essential health products.

Her appointment also underscores Liberia’s growing engagement in continental health initiatives and reflects the country’s commitment to strengthening Africa’s collective capacity to manufacture, regulate, procure, and distribute health products for the benefit of African populations.

Through Dr. Quaye-Freeman’s participation, Liberia is positioned to contribute its regulatory and public-health expertise to the APPM while supporting broader African Union efforts to build resilient, self-reliant, and sustainable health-product systems across the continent.

Pictorial Highlighting LMHRA 3-Day Strategic Working Session in Gompa City, Nimba County.
14/08/2026

Pictorial Highlighting LMHRA 3-Day Strategic Working Session in Gompa City, Nimba County.

LMHRA Convenes 3-Day Strategic Working Session -to Develop 2027 Roadmap and BudgetGanta, Nimba County---Ahead of the Gov...
12/08/2026

LMHRA Convenes 3-Day Strategic Working Session
-to Develop 2027 Roadmap and Budget

Ganta, Nimba County---Ahead of the Government of Liberia’s 2027 annual budget submission for Ministries, Agencies and Corporations (MACs), the Liberia Medicines & Health Products Regulatory Authority (LMHRA) has convened a pivotal three-day strategy session in Ganta City to set the agency’s priorities and develop its 2027 budget.

The intensive session brings together key leadership and departmental heads to translate the Authority’s strategic priorities into actionable, measurable, and realistically funded targets.

Opening the session, LMHRA Managing Director Hon. Luke L. Bawo noted that, with the overarching strategic plan already in place, the focus now shifts to turning vision into reality. He urged the team to construct an Annual Implementation Plan (AIP) backed by a realistic, practical budget tailored to the country's health needs.

The Managing Director emphasized the importance of turning strategy into concrete reality: "Our strategic plan is in place. Now is the time to build a realistic implementation plan and budget that matches our vision for 2027," he said.

Outlining the core objectives of the three-day gathering, Dr. S. Michael Chu Nepay, acting Director of Program, Planning, Monitoring, Evaluation, Research and Statistics (PPMERS), pointed out that the delegation will review, refine, and align all departmental work plans before consolidating the final proposal.
Once finalized, the proposal will be submitted to the Ministry of Finance and Development Planning (MFDP) to secure necessary funding and resource.

The session's opening day concluded with detailed presentations from individual departments, setting a collaborative tone for the planning sessions ahead.

LMHRA Leadership Conducts Unannounced Visit To Global Pharmaceuticals -To Assess Local Manufacturing CapacityMONROVIA, L...
10/08/2026

LMHRA Leadership Conducts Unannounced Visit To Global Pharmaceuticals
-To Assess Local Manufacturing Capacity

MONROVIA, Liberia — August 10, 2026: In a move signaling heightened regulatory attention to Liberia’s domestic pharmaceutical industry, the leadership of the Liberia Medicines & Health Products Regulatory Authority (LMHRA) on Friday, August 7, 2026, paid an unannounced visit to Global Pharmaceuticals, the country’s only pharmaceutical manufacturing company.

The high-level delegation was headed by LMHRA Managing Director Hon. Luke L. Bawo, accompanied by Deputy Managing Director Dr. Patricia Quaye-Freeman and several senior-level staff of the authority.

Rather than relying solely on scheduled regulatory engagements, the LMHRA leadership used the surprise visit to obtain a direct assessment of the company’s operational realities, including its manufacturing facilities, equipment, production processes, workforce, and quality management systems.

The exercise is part of a broader regulatory and public-health agenda aimed at determining what Liberia currently has—and what it still needs—to build a stronger domestic pharmaceutical manufacturing industry.
At the center of the engagement is the question of capacity: whether Liberia’s existing pharmaceutical manufacturing infrastructure can be strengthened sufficiently to produce more quality-assured medicines locally and contribute meaningfully to national and internationally to medicine security.

The LMHRA assessment was also intended to identify operational and technical gaps that could affect the expansion or sustainability of local pharmaceutical production.

For Liberia, the development of domestic pharmaceutical manufacturing represents more than an industrial objective. It has implications for the country’s health-security architecture, particularly in reducing vulnerabilities associated with heavy dependence on imported medicines and international supply chains.
A stronger local manufacturing base could potentially support more reliable medicine availability, create specialized employment opportunities, develop technical expertise, and contribute to the growth of Liberia’s pharmaceutical and health-products sector.

However, increased local production must be accompanied by strong regulatory controls. The quality, safety, efficacy, and consistency of medicines remain central to public health, making the LMHRA’s regulatory oversight critical as Liberia seeks to expand domestic production. The unannounced assessment therefore provides an important regulatory snapshot of Global Pharmaceuticals’ current capabilities and the areas requiring further attention.

The LMHRA’s engagement with the company also reflects a dual mandate: protecting the public through effective regulation while supporting the development of legitimate local pharmaceutical manufacturing capacity. As Liberia continues to pursue greater self-reliance in essential health commodities, the capacity of Global Pharmaceuticals—and the regulatory environment surrounding it—will remain an important part of the national conversation on medicine security.

The latest visit by the LMHRA leadership consequently marks another step toward a more structured partnership between the regulator and local pharmaceutical manufacturers, with the ultimate objective of ensuring that medicines produced in Liberia meet the highest applicable quality standards.

FOR IMMEDIATE RELEASELMHRA Showcases Regulatory Progress At Global Drug Regulatory Conclave 2026 In IndiaMonrovia, Augus...
04/08/2026

FOR IMMEDIATE RELEASE

LMHRA Showcases Regulatory Progress At Global Drug Regulatory Conclave 2026 In India

Monrovia, August 2026– The Liberia Medicines & Health Products Regulatory Authority (LMHRA) represented Liberia at the Global Drug Regulatory Conclave (GDRC) 2026, held on July 30–31, 2026, at Bharat Mandapam in New Delhi, India.

The high-level international forum, jointly organized by India's Central Drugs Standard Control Organization (CDSCO) and the Pharmaceutical Export Promotion Council of India (PHARMEXCIL), brought together medicines regulatory authorities from more than 50 countries, alongside global pharmaceutical and healthcare stakeholders to advance regulatory cooperation and innovation.

Representing LMHRA, Dr. Matu K. Fayiah-Nyanti, Manager of the Post-Market Surveillance Unit, delivered a presentation titled: "Quality Without Borders: Shared Responsibility," highlighting Liberia's progress in strengthening medicines regulation through improved product registration, post-market surveillance, pharmacovigilance, laboratory oversight, quality assurance, and regulatory enforcement.

She emphasized LMHRA's collaboration with the Ministry of Health, law enforcement agencies, customs authorities, regional institutions, and international partners to combat counterfeit and substandard medical products while ensuring access to safe, effective, and quality-assured medicines. Dr. Fayiah-Nyanti also called for enhanced international regulatory cooperation and increased access to Indian Pharmacopoeia (IP) reference standards to strengthen Liberia's medicines quality testing capacity.

Following her return, Dr. Fayiah-Nyanti formally presented her GDRC Training Certificate to LMHRA Managing Director Hon. Dr. Luke L. Bawo and Deputy Managing Director Madam Patricia Qaye-Freeman. She expressed appreciation to the Authority for the opportunity and pledged to apply the knowledge acquired to further strengthen regulatory services and public health protection in Liberia.

The LMHRA leadership commended Dr. Fayiah-Nyanti for representing both the Authority and Liberia with distinction and encouraged her to share the knowledge and experience gained with colleagues. "This reflects LMHRA's continued commitment to institutional capacity building, professional development, and strengthening Liberia's medicines regulatory system," the leadership noted.

The Authority remains committed to ensuring that all medicines and health products available in Liberia meet the highest standards of quality, safety, and efficacy through innovation, collaboration, and international partnerships.
# # #

Media Contact
Risk Communications & Public Relations Unit
Liberia Medicines & Health Products Regulatory Authority
(LMHRA)

LMHRA Wraps Up Training To Boost Pharmaceutical and Healthcare Waste Management SkillsCAREYSBURG, Liberia, July 18, 2026...
21/07/2026

LMHRA Wraps Up Training To Boost Pharmaceutical and Healthcare Waste Management Skills

CAREYSBURG, Liberia, July 18, 2026—The Liberia Medicines and Health Products Regulatory Authority (LMHRA) has just wrapped up an intensive three-day training session focused on enhancing the skills and operational know-how of those tasked with managing pharmaceutical and healthcare waste.

Taking place from July 15–17, 2026, at the Authority's Waste Management Facility in Kings Farm, Careysburg, the training brought together 20 dedicated staff members from the Quality Control Laboratory (QCL) and the Pharmaceutical Waste Management Site. This initiative, organized by the Human Resource Department in partnership with the Office of the Training Manager, is part of LMHRA's ongoing dedication to workforce development and strengthening institutional capacity.

During the opening remarks, LMHRA Managing Director, Dr. Luke L. Bawo, highlighted the vital role that effective pharmaceutical and healthcare waste management plays in protecting public health and the environment. "Improper disposal of pharmaceutical and healthcare waste poses significant risks to public health and the environment, including the contamination of water sources, soil degradation, and adverse effects on local communities," Dr. Bawo stated.

He added, "This training aims to equip our personnel with the essential knowledge and practical skills needed to manage waste safely and in line with both national and international standards." Dr. Bawo encouraged the participants to take the insights and best practices gained from the training and apply them to enhance the Authority's waste management efforts, ultimately supporting Liberia's broader public health goals.

In addition, Waste Management Site Manager Francis S. Mulbah reiterated LMHRA's commitment to ensuring that pharmaceutical and healthcare waste management systems are safe, efficient, and environmentally responsible. He emphasized that ongoing investment in developing staff capabilities is crucial for meeting regulatory standards while also enhancing operational efficiency and environmental responsibility.

During the three-day program, participants engaged in both classroom learning and hands-on demonstrations that spanned a wide array of technical and regulatory subjects. These included: classifying and segregating pharmaceutical and healthcare waste; safe procedures for handling and disposing of waste; practices for occupational health and safety; measures for infection prevention and control; the correct use of Personal Protective Equipment (PPE); protocols for waste reception, storage, and transportation; healthcare waste incineration technology; operating equipment and preventive maintenance; as well as documentation, monitoring, and reporting systems; and national policies, regulations, and international best practices related to healthcare waste management.

The participants hailed from key operational units within the Authority, such as site managers, supervisors, health and safety officers, incinerator operators, maintenance officers, laboratory technicians, waste reception officers, and other technical staff involved in waste management. This multidisciplinary training was led by experts from various departments within LMHRA, showcasing the Authority's cohesive approach to institutional learning, regulatory adherence, and operational excellence.

By enhancing the skills of frontline staff, this initiative underscores LMHRA's dedication to managing pharmaceutical and healthcare waste in a safe, responsible, and sustainable manner, all while reducing environmental risks and safeguarding communities. This training is part of LMHRA's larger strategy to cultivate a highly skilled workforce that can effectively regulate medicines and health products, as well as promote environmental sustainability throughout Liberia's healthcare system.

Established by an Act of the National Legislature in 2010, the Liberia Medicines and Health Products Regulatory Authority (LMHRA) is mandated to ensure the safety, quality, and efficacy of medicines and health products, and to properly regulate them in Liberia, thereby protecting and promoting public health.

Address

Mamba Point
Monrovia

Opening Hours

Monday 09:00 - 17:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 17:00

Telephone

+231777140555

Alerts

Be the first to know and let us send you an email when Liberia Medicines & Health Products Regulatory Authority posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Liberia Medicines & Health Products Regulatory Authority:

Shortcuts

Share